131 related articles for article (PubMed ID: 35191648)
1. Vaccinal Efficacy of Recombinant Marek's Disease Vaccine 301B/1 Expressing Chicken Interleukin-15.
Kim T; Hearn C
Avian Dis; 2022 Mar; 66(1):79-84. PubMed ID: 35191648
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of Recombinant Marek's Disease Virus Vaccine 301B/1 Expressing Membrane-Anchored Chicken Interleukin-15.
Kim T; Hearn C; Heidari M
Avian Dis; 2024 Jun; 68(2):117-128. PubMed ID: 38885053
[TBL] [Abstract][Full Text] [Related]
3. Vaccinal efficacy of molecularly cloned
Kim T; Spatz SJ; Dunn JR
J Gen Virol; 2020 May; 101(5):542-552. PubMed ID: 32134378
[TBL] [Abstract][Full Text] [Related]
4. Towards a mechanistic understanding of the synergistic response induced by bivalent Marek's disease vaccines to prevent lymphomas.
Umthong S; Dunn JR; Cheng HH
Vaccine; 2019 Oct; 37(43):6397-6404. PubMed ID: 31515142
[TBL] [Abstract][Full Text] [Related]
5. Pathotyping of Australian isolates of Marek's disease virus in commercial broiler chickens vaccinated with herpesvirus of turkeys (HVT) or bivalent (HVT/SB1) vaccine and association with viral load in the spleen and feather dander.
Walkden-Brown SW; Islam A; Islam AF; Burgess SK; Groves PJ; Cooke J
Aust Vet J; 2013 Aug; 91(8):341-50. PubMed ID: 23889101
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional Analyses of Innate and Acquired Immune Patterning Elicited by Marek's Disease Virus Vaccine Strains: Turkey Herpesvirus (HVT), Marek's Disease Virus 2 (strain SB1), and Bivalent Vaccines (HVT/SB1 and HVT-LT/SB1).
Neerukonda SN; Katneni UK; Bhandari N; Parcells MS
Avian Dis; 2019 Dec; 63(4):670-680. PubMed ID: 31865682
[TBL] [Abstract][Full Text] [Related]
7. Protection and synergism by recombinant fowl pox vaccines expressing genes from Marek's disease virus.
Nazerian K; Witter RL; Lee LF; Yanagida N
Avian Dis; 1996; 40(2):368-76. PubMed ID: 8790888
[TBL] [Abstract][Full Text] [Related]
8. Interferon-γ influences immunity elicited by vaccines against very virulent Marek's disease virus.
Haq K; Elawadli I; Parvizi P; Mallick AI; Behboudi S; Sharif S
Antiviral Res; 2011 Jun; 90(3):218-26. PubMed ID: 21501630
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the Protection Efficacy of a Serotype 1 Marek's Disease Virus-Vectored Bivalent Vaccine Against Infectious Laryngotracheitis and Marek's Disease.
Gimeno IM; Cortes AL; Faiz NM; Hernandez-Ortiz BA; Guy JS; Hunt HD; Silva RF
Avian Dis; 2015 Jun; 59(2):255-62. PubMed ID: 26473676
[TBL] [Abstract][Full Text] [Related]
10. Load of challenge Marek's disease virus DNA in blood as a criterion for early diagnosis of Marek's disease tumors.
Gimeno IM; Cortes AL; Silva RF
Avian Dis; 2008 Jun; 52(2):203-8. PubMed ID: 18646447
[TBL] [Abstract][Full Text] [Related]
11. Protective efficacy of Marek's disease virus (MDV) CVI-988 CEF65 clone C against challenge infection with three very virulent MDV strains.
de Boer GF; Groenendal JE; Boerrigter HM; Kok GL; Pol JM
Avian Dis; 1986; 30(2):276-83. PubMed ID: 3015113
[TBL] [Abstract][Full Text] [Related]
12. Effect of Pre-Treatment with a Recombinant Chicken Interleukin-17A on Vaccine Induced Immunity against a Very Virulent Marek's Disease Virus.
Boodhoo N; Matsuyama-Kato A; Raj S; Fazel F; St-Denis M; Sharif S
Viruses; 2023 Jul; 15(8):. PubMed ID: 37631976
[TBL] [Abstract][Full Text] [Related]
13. The efficacy of recombinant fowlpox vaccine protection against Marek's disease: its dependence on chicken line and B haplotype.
Lee LF; Bacon LD; Yoshida S; Yanagida N; Zhang HM; Witter RL
Avian Dis; 2004; 48(1):129-37. PubMed ID: 15077806
[TBL] [Abstract][Full Text] [Related]
14. Construction of Recombinant HVT Expressing PmpD, and Immunological Evaluation against Chlamydia psittaci and Marek's Disease Virus.
Liu S; Sun W; Chu J; Huang X; Wu Z; Yan M; Zhang Q; Zhao P; Igietseme JU; Black CM; He C; Li Y
PLoS One; 2015; 10(4):e0124992. PubMed ID: 25893439
[TBL] [Abstract][Full Text] [Related]
15. Effect of diluting Marek's disease vaccines on the outcomes of Marek's disease virus infection when challenged with highly virulent Marek's disease viruses.
Gimeno IM; Cortes AL; Montiel ER; Lemiere S; Pandiri AK
Avian Dis; 2011 Jun; 55(2):263-72. PubMed ID: 21793444
[TBL] [Abstract][Full Text] [Related]
16. Relationship between Marek's disease virus load in peripheral blood lymphocytes at various stages of infection and clinical Marek's disease in broiler chickens.
Islam AF; Walkden-Brown SW; Islam A; Underwood GJ; Groves PJ
Avian Pathol; 2006 Feb; 35(1):42-8. PubMed ID: 16448942
[TBL] [Abstract][Full Text] [Related]
17. Effects of T-2 Toxin on Turkey Herpesvirus-Induced Vaccinal Immunity Against Marek's Disease.
Kufuor-Mensah E; Reed WM; Sleight S; Pestka J; Fadly AM; Dunn JR
Avian Dis; 2016 Mar; 60(1):56-62. PubMed ID: 26953944
[TBL] [Abstract][Full Text] [Related]
18. Host genetic resistance to Marek's disease sustains protective efficacy of herpesvirus of turkey in both experimental and commercial lines of chickens.
Chang S; Xie Q; Dunn JR; Ernst CW; Song J; Zhang H
Vaccine; 2014 Apr; 32(16):1820-7. PubMed ID: 24530405
[TBL] [Abstract][Full Text] [Related]
19. Avirulent Marek's disease virus type 1 strain 814 vectored vaccine expressing avian influenza (AI) virus H5 haemagglutinin induced better protection than turkey herpesvirus vectored AI vaccine.
Cui H; Gao H; Cui X; Zhao Y; Shi X; Li Q; Yan S; Gao M; Wang M; Liu C; Wang Y
PLoS One; 2013; 8(1):e53340. PubMed ID: 23301062
[TBL] [Abstract][Full Text] [Related]
20. Effects of administration of probiotic lactobacilli on immunity conferred by the herpesvirus of turkeys vaccine against challenge with a very virulent Marek's disease virus in chickens.
Bavananthasivam J; Alizadeh M; Astill J; Alqazlan N; Matsuyama-Kato A; Shojadoost B; Taha-Abdelaziz K; Sharif S
Vaccine; 2021 Apr; 39(17):2424-2433. PubMed ID: 33781599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
